| Literature DB >> 26687948 |
Makoto Honda1, Itsunari Minami2, Norie Tooi2, Nobuhiro Morone2, Hisae Nishioka2, Kengo Uemura3, Ayae Kinoshita4, John E Heuser5, Norio Nakatsuji6, Kazuhiro Aiba7.
Abstract
Cellular disease models are useful tools for Alzheimer's disease (AD) research. Pluripotent stem cells, including human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), are promising materials for creating cellular models of such diseases. In the present study, we established cellular models of AD in hESCs that overexpressed the mutant Presenilin 1 (PS1) gene with the use of a site-specific gene integration system. The overexpression of PS1 did not affect the undifferentiated status or the neural differentiation ability of the hESCs. We found increases in the ratios of amyloid-β 42 (Aβ42)/Aβ40 and Aβ43/Aβ40. Furthermore, synaptic dysfunction was observed in a cellular model of AD that overexpressed mutant PS1. These results suggest that the AD phenotypes, in particular, the electrophysiological abnormality of the synapses in our AD models might be useful for AD research and drug discovery.Entities:
Keywords: Alzheimer's disease; Cellular disease model; Human embryonic stem cell; Presenilin 1; Synaptic dysfunction
Mesh:
Substances:
Year: 2015 PMID: 26687948 DOI: 10.1016/j.bbrc.2015.12.025
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575